Lyra Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
28 Feb 2023	Form 3: Bishop John E, Chief Technology Officer No securities owned
12 Jul 2022	Form 3: Nieman Richard, Chief Medical Officer No securities owned
08 Mar 2022	Form 3: Tobin James R, Director No securities owned
18 Feb 2022	Form 3: Waksal Harlan, Director No securities owned
15 Sep 2021	Form 3: Cavalier Jason, Chief Financial Officer No securities owned
29 Oct 2020	Form 3: snyderman nancy lynn Md, Director No securities owned
05 Aug 2020	Form 3: Nelson Pamela E., Senior VP, Regulatory Affairs No securities owned
26 Jun 2020	Form 3: Richard Robert E., SVP of R&D No securities owned
15 May 2020	Form 3: Soleus Private Equity Gp I, Llc, 10% owner and 3 others
30 Apr 2020	Form 3: Perceptive Advisors Llc, Director and 3 others
30 Apr 2020	Form 3: Polaris Venture Management Co. V, L.l.c., 10% owner and 6 others
30 Apr 2020	Form 3: Polaris Venture Management Co Iv Llc, 10% owner and 2 others
30 Apr 2020	Form 3: Nbvm GP, Llc, 10% owner and 6 others
30 Apr 2020	Form 3: Whitesides George M, Director Holds 28,999 shares of Common Stock
30 Apr 2020	Form 3: Roberts Carmichael, 10% owner Holds 57,999 shares of Common Stock
30 Apr 2020	Form 3: Anderson Edward T, Director
30 Apr 2020	Form 3: Smith W Bradford, Director
30 Apr 2020	Form 3: Altman Michael Seth, Director No securities owned
30 Apr 2020	Form 3: Mott Richard W, 10% owner Holds 50,462 shares of Common Stock
30 Apr 2020	Form 3: Merrifield C Ann, Director

Comments